First AAN Medical Online Education Series for 2026
Mar 26, 2026 Time: 10:00 am - 11:00 am
The Australian Amyloidosis Network is pleased to present the first online education session for 2026, focusing on current clinical trials in Amyloidosis in Australia.
This session will provide an overview of how clinical trials in AL and ATTR Amyloidosis have evolved over the past five years, along with information about currently recruiting trials and eligibility criteria.
📅 Date: Thursday 26 March 2026
⏰ Time: 10:00 AM – 11:00 AM (AEST)
Program
10:00 AM
Current Trials in AL Amyloidosis
Presented by Lisa Fisher
Haematology Trial Coordination
Westmead Hospital
10:30 AM
Current Trials in ATTR Amyloidosis
Presented by Helen Knight
Clinical Trials Manager
Westmead Hospital
Both speakers will discuss:
• How clinical trials have evolved over the past 5 years
• Current trials recruiting in Australia
• Eligibility criteria for patients considering participation
Submit Your Questions
Attendees are encouraged to submit questions in advance. These will be shared with the speakers beforehand so they can address them during the session.
📧 Send questions to: patientadvocate@aan.org.au
Why Attend?
This is a valuable opportunity for patients, families, and healthcare professionals to learn about the latest clinical trial opportunities in Australia and better understand potential pathways for treatment and research participation.
Microsoft Teams meeting
Meeting ID: 442 346 402 552 94
Passcode: To6pB3Xc
